August 27, 2019 / 9:42 PM / 3 months ago

CORRECTED-(OFFICIAL)-BRIEF-Bio-Rad Posts Q2 EPS Of $19.86 (Aug. 1)

(Corrects Q2 non-GAAP EPS in second bullet to $1.49, from $1.57, as the company's prior press release contained a $3.37 million error related to legal matters)

Aug 27 (Reuters) - Bio Rad Laboratories Inc:

* BIO-RAD REPORTS SECOND-QUARTER 2019 FINANCIAL RESULTS

* Q2 NON-GAAP EARNINGS PER SHARE $1.49

* Q2 EARNINGS PER SHARE $19.86

* Q2 SALES $572.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $566.2 MILLION

* Q2 EARNINGS PER SHARE ESTIMATE $1.34 -- REFINITIV IBES DATA

* FOR FY 2019, COMPANY CONTINUES TO ANTICIPATE CURRENCY-NEUTRAL REVENUE GROWTH OF APPROXIMATELY 4.0 TO 4.5% Source text: (bit.ly/2ztrkyE) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below